Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA04000037 16(17) EpDPE cPLA2i 1.0 BCD110605C28 0.104 pmol/ml medium
LMFA04000037 16(17) EpDPE cPLA2i 1.0 BCD110605C30 0.07 pmol/ml medium
LMFA04000037 16(17) EpDPE cPLA2i 1.0 BCD110605C29 0.097 pmol/ml medium
LMFA04000037 16(17) EpDPE cPLA2i 20.0 BCD110605C64 0.215 pmol/ml medium
LMFA04000037 16(17) EpDPE cPLA2i 20.0 BCD110605C66 0.195 pmol/ml medium
LMFA04000037 16(17) EpDPE cPLA2i 20.0 BCD110605C65 0.175 pmol/ml medium
LMFA04000037 16(17) EpDPE PLDi 1.0 BCD110605C16 0.101 pmol/ml medium
LMFA04000037 16(17) EpDPE PLDi 1.0 BCD110605C17 0.068 pmol/ml medium
LMFA04000037 16(17) EpDPE PLDi 1.0 BCD110605C18 0.067 pmol/ml medium
LMFA04000037 16(17) EpDPE PLDi 20.0 BCD110605C54 0.256 pmol/ml medium
LMFA04000037 16(17) EpDPE PLDi 20.0 BCD110605C52 0.276 pmol/ml medium
LMFA04000037 16(17) EpDPE PLDi 20.0 BCD110605C53 0.247 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+cPLA2i 1.0 BCD110605C32 0.098 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+cPLA2i 1.0 BCD110605C31 0.092 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+cPLA2i 1.0 BCD110605C33 0.082 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+cPLA2i 20.0 BCD110605C68 0.182 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+cPLA2i 20.0 BCD110605C69 0.21 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+cPLA2i 20.0 BCD110605C67 0.227 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+PLDi 1.0 BCD110605C19 0.097 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+PLDi 1.0 BCD110605C20 0.075 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+PLDi 1.0 BCD110605C21 0.083 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+PLDi 20.0 BCD110605C56 0.245 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+PLDi 20.0 BCD110605C57 0.305 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+PLDi 20.0 BCD110605C55 0.254 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.093 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.066 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.078 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.147 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.135 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.18 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+PLDi 1.0 BCD110605C25 0.074 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+PLDi 1.0 BCD110605C27 0.074 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+PLDi 1.0 BCD110605C26 0.079 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+PLDi 20.0 BCD110605C61 0.169 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+PLDi 20.0 BCD110605C62 0.182 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO+ATP+PLDi 20.0 BCD110605C63 0.164 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO + ATP 1.0 BCD110605C15 0.08 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO + ATP 1.0 BCD110605C14 0.085 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO + ATP 1.0 BCD110605C13 0.053 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO + ATP 20.0 BCD110605C49 0.206 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO + ATP 20.0 BCD110605C50 0.209 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO + ATP 20.0 BCD110605C51 0.18 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO 1.0 BCD110605C08 0.108 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO 1.0 BCD110605C07 0.069 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO 1.0 BCD110605C09 0.104 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO 20.0 BCD110605C45 0.308 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO 20.0 BCD110605C44 0.258 pmol/ml medium
LMFA04000037 16(17) EpDPE KDO 20.0 BCD110605C43 0.292 pmol/ml medium
LMFA04000037 16(17) EpDPE C 0.0 BCD110605C03 0.053 pmol/ml medium
LMFA04000037 16(17) EpDPE C 0.0 BCD110605C01 0.045 pmol/ml medium